Glucose control using an advanced hybrid closed-loop system
Not Applicable
Completed
- Conditions
- Type 1 diabetesMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12618000840280
- Lead Sponsor
- St Vincent's Hospital Melbourne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Type 1 diabetes of >1 year duration
Stable on insulin pump therapy for >3 months
Proficient in carbohydrate counting
Continuous glucose monitoring (CGM) sensor experience
HbA1c <10.0%
Exclusion Criteria
Pregnancy
eGFR<40
History of diabetic ketoacidosis or severe hypoglycaemia in the last 3 months
Diabetic gastroparesis
Unable to exercise
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total % continuous glucose monitoring (CGM) time spent within target glucose range (3.9–10mmol/L) using CGM data uploaded from the MiniMed Medtronic device <br>[Measured for 4 weeks (Stage 1 – 3 of the study [ie. Week 2, 3, 4, 5])]
- Secondary Outcome Measures
Name Time Method